Related Experiment Video
Updated: May 28, 2025
11:32
Mapping RNA-RNA Interactions Globally Using Biotinylated Psoralen
Published on: May 24, 2017
12.0K
YRNAs: biosynthesis, structure, functions and involvment in cancer development
Adele Campo1, Federica Aliquò2, Tania Velletri3
1Department of Clinical and Experimental Medicine, University of Messina, Policlinico Universitario, via Consolare Valeria, 1, 98125, Messina, Italy.
Discover Oncology
|February 13, 2025
Summary
Y RNAs and their derived small RNAs (YsRNAs) are bioactive molecules regulating cellular processes and protein interactions. These small non-coding RNAs show potential as disease biomarkers and therapeutic targets in personalized medicine.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Y RNAs are highly conserved small non-coding RNAs.
- Emerging evidence suggests Y RNAs and YsRNAs are bioactive, not just structural.
- They regulate RNA-binding proteins in crucial cellular processes like DNA replication and stress responses.
Purpose of the Study:
- To review the current knowledge on Y RNAs, including their structure, biogenesis, and functions.
- To explore the interactions of Y RNAs with proteins.
- To discuss the role of Y RNAs in various diseases.
Main Methods:
- Literature review of existing research on Y RNAs.
- Analysis of studies on Y RNA structure and biogenesis.
- Examination of evidence linking Y RNAs to cellular functions and diseases.
Main Results:
- Y RNAs and YsRNAs interact with and regulate RNA-binding proteins.
- Functional involvement of Y RNAs is implicated in cancer, immune disorders, neurological, and cardiovascular diseases.
- Y RNAs have potential as biomarkers for disease diagnosis and therapeutic targets.
Conclusions:
- Y RNAs are key players in cellular regulation and disease pathogenesis.
- Further research is needed for a complete understanding of Y RNA mechanisms.
- Y RNAs offer promise for personalized medicine approaches.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
02:55The Nucleolus
8.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
02:38The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K